Draft rules give Monitor power to investigate anticompetitive behaviour by commissioning groupsBMJ 2012; 345 doi: http://dx.doi.org/10.1136/bmj.e5618 (Published 20 August 2012) Cite this as: BMJ 2012;345:e5618
- Matthew Limb
The government has drafted new rules to police conflicts of interests and anticompetitive conduct involving the new clinical commissioning groups in England and has invited views on whether additional safeguards are needed.
A consultation published on 15 August by the Department of Health outlines the regulations and the role of the health regulator Monitor in investigating alleged breaches of conduct.1
It says that commissioners would be “specifically prohibited” from awarding a contract to a provider “where that decision is the result of an interest in the provider.”
In the event of complaints, commissioners would have to show how they managed the potential …
Log in using your username and password
Log in through your institution
Register for a free trial to thebmj.com to receive unlimited access to all content on thebmj.com for 14 days.
Sign up for a free trial